Search Results

HRP20 Supporting and Maintaining Attendance Policy

v2 November 2025

FINAL Chief Executive Designate - Stakeholder Briefing - 11 November 2021.pdf

Dr Chris Clayton appointment; Chief Executive JUCD

Transfer of Care Protocol (S14)

1.1 The purpose of these joint procedures is to minimise delays for all adult patients assessed as fit for transfer including those who need Care Packages at home, permanent Care Home Placements whether publicly funded, self-funded, or fully funded by NHS Continuing Care or Terminal Care as described in the NHS Continuing Care National Framework (Revised November 2018.) These procedures will ensure efficient bed utilisation.

Safe to Wait SOP for Band 3 HCAs (S76)

The rationale for introducing a “Safe to Wait” process is, for when patients present to UTC Services, the first point of contact will usually be the Reception/HCA staff. The Safe to Wait Guidance will be undertaken by Health Care Assistant (Band 3) staff following specific training and a period of demonstrating competence for the assessment of patients attending the UTCs with specific conditions/injuries. This will ensure that Band 3 HCA’s are aware of “Red Flag Signs”, and symptoms that indicate that someone presenting at the unit may require immediate or urgent attention.

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

Employee online user guide - temporary staffing.pdf

Disclosure Ref 202243 - Agency for Biomedical SciencePathology - Copy.pdf

WRES data report 2023.docx

APPENDIX 4 Application for Adoption Leave and Pay Form.docx

Organisational strategy - Bitesize slides - Healthy Communities.pptx

Organisational strategy - Bitesize slides - Healthy Communities.pptx